Xenon PharmaceuticalsNASDAQ: XENE: Developing therapeutics for neurological and psychiatric disorders.
10+ YOEPhD in Chemistry or Chemical Engineering with 10+ years API CDMO experience; regulatory CMC writing; CDMO selection and tech transfer; extensive cGMP knowledge.
Director, Commercial Manufacturing & Process Engineering
Waltham, Massachusetts, United States
$184k-$253k/yrRemoteFull Time
Deciphera Pharmaceuticals: Developing targeted kinase inhibitors for the treatment of cancer.
10+ YOE10+ years in pharmaceutical/biopharmaceutical CMC development, commercialization, and manufacturing; leadership; cGMP; CDMO/CMO experience; travel up to 30%.
Director, Peptide Process Development (Cambridge, MA, US, 02142)
Cambridge, Massachusetts, United States
$197k-$267k/yrOnsiteFull Time
AlnylamNasdaq: ALNY: Developing and commercializing RNA interference (RNAi) therapeutics for diseases.
10+ YOEPhD with 10+ years in peptide or conjugate process development; experience leading CDMO collaborations and GMP manufacturing; strong regulatory documentation experience.
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
5+ YOE1+ MgmtBachelor's degree in a scientific discipline; 5+ years in pharma QA/compliance; experience with CDMOs, sterile products, and cGMP; strong regulatory knowledge.
Dyne TherapeuticsNASDAQ: DYN: Developing therapeutics for genetically driven neuromuscular diseases.
10+ YOE10+ years biopharma experience in biologics process development, CDMO management, CMC strategy, regulatory authoring (Module 3), and leadership in a matrixed environment.
Senior Director, Commercial Manufacturing, Science and Technology
United States or Waltham or Boulder
$240k-$280k/yrRemoteFull Time
Cogent BiosciencesNASDAQ: COGT: Develops precision therapies for genetically defined diseases
20+ YOE12+ MgmtLead CDMO CMC lifecycle for late-stage to commercial, 20+ years biotech/pharma; strong regulatory, vendor management, and cross-functional leadership.
cGMP, CDMO coordination, Process Validation, IND, IMPD, CMC, Regulatory Filings
Genetix Biotherapeutics: Developing and commercializing curative gene therapies for rare diseases.
7+ YOEBachelor’s in STEM; 7+ years in regulated biopharma with cGMP; lot disposition/batch review; CMOs/CDMOs experience; GMP docs; electronic systems usage.
eQMS, LIMS, Document Management Systems, Batch Record Management
Kymera TherapeuticsNASDAQ: KYMR: Develops targeted protein degradation medicines to treat human diseases.
15+ YOEPhD and 15+ years pharmaceutical experience in early-stage formulation development, expertise in preformulation, biopharmaceutics, enabling technologies, GMP/regulatory knowledge, and CRO/CDMO management.
Crescent BiopharmaNASDAQ: CBIO: Develops novel oncology therapies and antibody-drug conjugates for cancer.
8+ YOEBachelor's in life sciences,8+ years GMP QA experience for biologics,experience with CDMOs,tech transfer,PPQ,BLA support,knowledge of global GMP and regulatory submissions.
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
10+ YOE10+ years sourcing/CDMO experience in pharmaceuticals, strong negotiation and supplier management, leadership and team development, contract and risk management, analytical skills, familiarity with GMP and regulatory standards.
Korsana BiosciencesNASDAQ: CYCN: Develops novel therapies to treat neurodegenerative diseases.
10+ YOEPhD or MS/BS with equivalent experience in chemistry/chemical engineering or life sciences; 10+ years biologics drug product experience, CMC and CDMO management, regulatory submission experience.
Sr. Business Development Executive - Biotech Solutions (New England)
Boston, Massachusetts, United States
$128k-$192k/yrRemoteFull Time
Thermo Fisher ScientificNYSE: TMO: Sells equipment and chemicals for scientific research and healthcare.
5+ YOE5+ years quota-carrying field sales or business development in CDMO services; hunter mindset; proven new logo wins and multi-year contracts; willing to travel up to 50%.
Associate Director, Analytical Development & Quality Control
Boston, Massachusetts, United States
OnsiteFull Time
Alpha-9 Oncology: Developing targeted radiopharmaceuticals for the treatment of cancer
8+ YOE5+ MgmtPh.D. with ≥8 years or M.S. with ≥11 years in analytical chemistry/radiochemistry; ≥5 years managing CDMOs; experience with analytical method lifecycle, investigations, OOS/OOT, CAPA, and cGMP/ICH requirements.
Viridian TherapeuticsNASDAQ: VRDN: Developing optimized treatments for rare autoimmune conditions.
5+ YOE5+ years QA experience in biotech/pharma/medical device, Bachelor's in Life Science or Engineering, complaint handling, experience with CDMOs, Veeva eQMS, knowledge of US/global GMP and ICH guidelines.
Veeva Quality Management System, Microsoft Word, Microsoft PowerPoint, Microsoft Excel, Microsoft Outlook, Microsoft SharePoint
Parabilis Medicines: Developing helical peptide therapeutics for undruggable cancer targets.
8+ YOEPhD in a related field; 8-10+ years drug product development experience for peptides; expertise in parenteral and oral dosage forms; experience with CRO/CDMO and IND/CMC activities; leadership and collaboration skills.
Parenteral formulations, Oral dosage forms, Formulation development, CMC, IND
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
10+ YOEPhD in a relevant scientific discipline, 10+ years industry experience in peptide/POC process development, CDMO management and process transfer experience, regulatory CMC documentation experience, and cross-functional leadership ability.
AlkermesNASDAQ: ALKS: Develops medicines for psychiatric and neurological disorders.
PhD (>8 yrs) or MS (>15 yrs) in Science/Engineering; expert in small-molecule process development, scale-up, tech transfer, DOE, data analysis, CDMO management; strong leadership and communication.